TY - JOUR T1 - Drug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry? JF - Drug Metabolism and Disposition JO - Drug Metab Dispos DO - 10.1124/dmd.115.065714 SP - dmd.115.065714 AU - Hollie I Swanson Y1 - 2015/01/01 UR - http://dmd.aspetjournals.org/content/early/2015/08/06/dmd.115.065714.abstract N2 - The importance of the gut microbiome in not only determining overall health, but also in the metabolism of drugs and xenobiotics is rapidly emerging. It is becoming increasingly clear that the gut microbiota can act in concert with the host cells to maintain intestinal homeostasis, co-metabolize drugs and xenobiotics and alter the expression levels of drug metabolizing enzymes, transporters and the expression and activity levels of nuclear receptors. In this myriad of activities, the impact of the microbiota may be beneficial or detrimental to the host. Given that the interplay between the gut microbiota and host cells is likely subject to high inter-individual variability, this work has tremendous implications for our ability to accurately predict a particular drug's pharmacokinetics and a given patients population's response to drugs. In this issue of Drug Metabolism and Disposition, a series of articles is presented that illustrate the progress and challenges that lie ahead as we unravel the intricacies associated with drug and xenobiotic metabolism by the gut microbiota. The articles highlight the underlying involved mechanisms and the use of in vivo and in vitro approaches that are currently available for their use in elucidating the role of the gut microbiota in drug/xenobiotic metabolism. They also shed light on exciting new avenues of research that may be pursued as we consider the role of the gut microbiota as an endocrine organ, a component of the brain-gut axis and whether the gut microbiota is an appropriate and amenable target for new drugs. ER -